| Carrie B Nicholson, MD | |
|
302 N Monroe St Ste A, Albion, MI 49224-1765 | |
| (517) 629-2134 | |
| Not Available |
| Full Name | Carrie B Nicholson |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 21 Years |
| Location | 302 N Monroe St Ste A, Albion, Michigan |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356366819 | NPI | - | NPPES |
| CN083244 | Other | MI | STATE MEDICAL LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | CN083244 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Great Lakes Caring | Jackson, MI | Home health agency |
| Oaklawn Hospital | Marshall, MI | Hospital |
| Henry Ford Allegiance Health | Jackson, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ella E M Brown Charitable Circle | 1254228745 | 98 |
News Archive
Scientists have known for the last decade that a link exists between wound healing and cancer. For instance, in a 1994 experiment at the Lawrence Berkeley National Laboratory, chickens infected with a cancer virus developed tumors in areas of their body that had undergone wounding or scarring, while no tumors developed in infected areas that had not suffered wounding.
Eisai Co., Ltd. and Merck & Co., Inc., Kenilworth N.J., U.S.A., known as MSD outside of the United States and Canada, announced today that the European Commission has granted a marketing authorization for the oral receptor tyrosine kinase inhibitor LENVIMA (lenvatinib mesylate) as a single agent for the first-line treatment of adult patients with advanced or unresectable hepatocellular carcinoma who have received no prior systemic therapy.
When a rural community loses its hospital, health care becomes harder to come by in an instant. But a hospital closure also shocks a small town's economy. It shuts down one of its largest employers.
Building on its reputation as a global technology leader in laser and light-based aesthetic systems, Cynosure, Inc. today announced that it has acquired the assets of the aesthetic laser business of HOYA ConBio, a wholly owned subsidiary of Japan-based HOYA Corporation, for $24.5 million in cash. HOYA ConBio is based in Fremont, California.
COVID-19 and vaccine hesitancy did not stop the Philippines from stamping out a polio outbreak in a 16-month drive that ended June 2021, a feat commended by WHO and UNICEF.
› Verified 8 days ago
| Entity Name | W.a. Foote Memorial Hospital, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760437826 PECOS PAC ID: 0244136067 Enrollment ID: O20031212000691 |
News Archive
Scientists have known for the last decade that a link exists between wound healing and cancer. For instance, in a 1994 experiment at the Lawrence Berkeley National Laboratory, chickens infected with a cancer virus developed tumors in areas of their body that had undergone wounding or scarring, while no tumors developed in infected areas that had not suffered wounding.
Eisai Co., Ltd. and Merck & Co., Inc., Kenilworth N.J., U.S.A., known as MSD outside of the United States and Canada, announced today that the European Commission has granted a marketing authorization for the oral receptor tyrosine kinase inhibitor LENVIMA (lenvatinib mesylate) as a single agent for the first-line treatment of adult patients with advanced or unresectable hepatocellular carcinoma who have received no prior systemic therapy.
When a rural community loses its hospital, health care becomes harder to come by in an instant. But a hospital closure also shocks a small town's economy. It shuts down one of its largest employers.
Building on its reputation as a global technology leader in laser and light-based aesthetic systems, Cynosure, Inc. today announced that it has acquired the assets of the aesthetic laser business of HOYA ConBio, a wholly owned subsidiary of Japan-based HOYA Corporation, for $24.5 million in cash. HOYA ConBio is based in Fremont, California.
COVID-19 and vaccine hesitancy did not stop the Philippines from stamping out a polio outbreak in a 16-month drive that ended June 2021, a feat commended by WHO and UNICEF.
› Verified 8 days ago
| Entity Name | Ella E M Brown Charitable Circle |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366591794 PECOS PAC ID: 1254228745 Enrollment ID: O20040616001008 |
News Archive
Scientists have known for the last decade that a link exists between wound healing and cancer. For instance, in a 1994 experiment at the Lawrence Berkeley National Laboratory, chickens infected with a cancer virus developed tumors in areas of their body that had undergone wounding or scarring, while no tumors developed in infected areas that had not suffered wounding.
Eisai Co., Ltd. and Merck & Co., Inc., Kenilworth N.J., U.S.A., known as MSD outside of the United States and Canada, announced today that the European Commission has granted a marketing authorization for the oral receptor tyrosine kinase inhibitor LENVIMA (lenvatinib mesylate) as a single agent for the first-line treatment of adult patients with advanced or unresectable hepatocellular carcinoma who have received no prior systemic therapy.
When a rural community loses its hospital, health care becomes harder to come by in an instant. But a hospital closure also shocks a small town's economy. It shuts down one of its largest employers.
Building on its reputation as a global technology leader in laser and light-based aesthetic systems, Cynosure, Inc. today announced that it has acquired the assets of the aesthetic laser business of HOYA ConBio, a wholly owned subsidiary of Japan-based HOYA Corporation, for $24.5 million in cash. HOYA ConBio is based in Fremont, California.
COVID-19 and vaccine hesitancy did not stop the Philippines from stamping out a polio outbreak in a 16-month drive that ended June 2021, a feat commended by WHO and UNICEF.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Carrie B Nicholson, MD 302 N Monroe St Ste A, Albion, MI 49224-1765 Ph: (517) 629-2134 | Carrie B Nicholson, MD 302 N Monroe St Ste A, Albion, MI 49224-1765 Ph: (517) 629-2134 |
News Archive
Scientists have known for the last decade that a link exists between wound healing and cancer. For instance, in a 1994 experiment at the Lawrence Berkeley National Laboratory, chickens infected with a cancer virus developed tumors in areas of their body that had undergone wounding or scarring, while no tumors developed in infected areas that had not suffered wounding.
Eisai Co., Ltd. and Merck & Co., Inc., Kenilworth N.J., U.S.A., known as MSD outside of the United States and Canada, announced today that the European Commission has granted a marketing authorization for the oral receptor tyrosine kinase inhibitor LENVIMA (lenvatinib mesylate) as a single agent for the first-line treatment of adult patients with advanced or unresectable hepatocellular carcinoma who have received no prior systemic therapy.
When a rural community loses its hospital, health care becomes harder to come by in an instant. But a hospital closure also shocks a small town's economy. It shuts down one of its largest employers.
Building on its reputation as a global technology leader in laser and light-based aesthetic systems, Cynosure, Inc. today announced that it has acquired the assets of the aesthetic laser business of HOYA ConBio, a wholly owned subsidiary of Japan-based HOYA Corporation, for $24.5 million in cash. HOYA ConBio is based in Fremont, California.
COVID-19 and vaccine hesitancy did not stop the Philippines from stamping out a polio outbreak in a 16-month drive that ended June 2021, a feat commended by WHO and UNICEF.
› Verified 8 days ago
Dr. Ndubisi Eze Izima, DO Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1302 N Eaton St, Albion, MI 49224 Phone: 517-629-9551 Fax: 517-629-9662 |